Woodline Partners’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Woodline Partners’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-533,114	Closed	-$33.1M	–	673
2023 Q4	$33.1M	Buy	533,114 +308,114	+137%	+$7.66M	0.36%	80
2023 Q3	$5M	Buy	+225,000	New	+$4.72M	0.06%	310

Woodline Partners's RYZB Position: Q1 2024 in Review

Woodline Partners sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 533,114 shares — an estimated $33.1M sold.

Woodline Partners first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $33.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Woodline Partners reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Woodline Partners sold 533,114 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $33.1M.
Woodline Partners first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Woodline Partners's RayzeBio, Inc. Common Stock position peaked at $33.1M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.